Gene · 2235
Papers1,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Insights on Ferroptosis Modulation as Potential Strategy for Cancer Treatment: When Nature Kills. | Antioxid Redox Signal | 2024 | 37132605 | PubTator, text mining | PubMed |
| Progress in pH-Sensitive sensors: essential tools for organelle pH detection, spotlighting mitochondrion and diverse applications. | Front Pharmacol | 2023 | 38269286 | PubTator, text mining | PubMed |
| Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria. | Pharmaceuticals (Basel) | 2023 | 38256864 | PubTator, text mining | PubMed |
| Cimetidine Does Not Inhibit 5-Aminolevulinic Acid Synthase or Heme Oxygenase Activity: Implications for Treatment of Acute Intermittent Porphyria and Erythropoietic Protoporphyria. | Biomolecules | 2023 | 38254627 | PubTator, text mining | PubMed |
| Photodynamic Therapy and Immunological View in Gastrointestinal Tumors. | Cancers (Basel) | 2023 | 38201494 | PubTator, text mining | PubMed |
| TGF-β-regulated different iron metabolism processes in the development and cisplatin resistance of ovarian cancer. | Oncol Res | 2023 | 38186569 | PubTator, text mining | PubMed |
| Pharmacological approaches to understanding protein kinase signaling networks. | Front Pharmacol | 2023 | 38164473 | PubTator, text mining | PubMed |
| Novel Iron-Chelating Prodrug Significantly Enhanced Fluorescence-Mediated Detection of Glioma Cells Experimentally In Vitro. | Pharmaceutics | 2023 | 38140009 | PubTator, text mining | PubMed |
| Translation Fidelity and Respiration Deficits in CLPP-Deficient Tissues: Mechanistic Insights from Mitochondrial Complexome Profiling. | Int J Mol Sci | 2023 | 38139332 | PubTator, text mining | PubMed |
| Exploring Thiazolopyridine AV25R: Unraveling of Biological Activities, Selective Anti-Cancer Properties and In Silico Target and Binding Prediction in Hematological Neoplasms. | Molecules | 2023 | 38138609 | PubTator, text mining | PubMed |
| The diagnosis of acute intermittent porphyria combined with seizures: Case report. | Medicine (Baltimore) | 2023 | 38115298 | PubTator, text mining | PubMed |
| Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients. | Discov Oncol | 2023 | 38112859 | PubTator, text mining | PubMed |
| Proton Compared to X-Irradiation Induces Different Protein Profiles in Oral Cancer Cells and Their Derived Extracellular Vesicles. | Int J Mol Sci | 2023 | 38069306 | PubTator, text mining | PubMed |
| Antitumor Effect of Poplar Propolis on Human Cutaneous Squamous Cell Carcinoma A431 Cells. | Int J Mol Sci | 2023 | 38069077 | PubTator, text mining | PubMed |
| Management of erythropoietic protoporphyria with cholestatic liver disease: A case report. | Mol Genet Metab Rep | 2023 | 38053924 | PubTator, text mining | PubMed |
| A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence. | Nat Commun | 2023 | 38052772 | PubTator, text mining | PubMed |
| The role of cytochrome P450 3A4-mediated metabolism in sorafenib and lapatinib hepatotoxicity. | Livers | 2023 | 38037613 | PubTator, text mining | PubMed |
| Unraveling the blue shift in porphyrin fluorescence in glioma: The 620 nm peak and its potential significance in tumor biology. | Front Neurosci | 2023 | 38027504 | PubTator, text mining | PubMed |
| Erythropoietic protoporphyria: case reports for clinical and therapeutic hints. | Ital J Pediatr | 2023 | 37996925 | PubTator, text mining | PubMed |
| [Research Progress of Nrf2 and Ferroptosis in Tumor Drug Resistance]. | Zhongguo Fei Ai Za Zhi | 2023 | 37989339 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2235/papers?page=6